miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma
Related Experiment Video
Updated: Dec 6, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Sun Lixin1, Sun Wei1, Song Haibin2
1Department of General Surgery, Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Abstract:
The incidence of intrahepatic cholangiocarcinoma (iCCA) continues to increase worldwide, however its molecular pathogenesis remains poorly understood. Recent studies have implicated microRNAs in iCCA progression. In this study, we demonstrated that miR-885-5p was significantly decreased in iCCA tissues. Downregulation of miR-885-5p was correlated with vascular invasion, lymph node metastasis, unfavorable overall survival, and shorter disease-free survival. Silencing or overexpressing miR-885-5p by lentiviral approaches significantly influenced iCCA cell proliferation and metastasis in vitro and in vivo. Mechanistically, overexpression of miR-885-5p inhibited iCCA metastasis and proliferation by directly inhibiting GALNT3 as well as by indirectly promoting the downregulation of insulin-like growth factor-2 mRNA-binding protein 1 (IGF2BP1). Furthermore, miR-885-5p inhibited iCCA metastasis by downregulating the PI3K/AKT/MMPs signaling pathway via targeting GALNT3. Collectively, we demonstrated that miR-885-5p was an important mediator of iCCA proliferation and metastasis by regulating GALNT3 and IGF2BP1, thus offering a potential target for iCCA treatment.
Insights
MicroRNA-885-5p (miR-885-5p) is decreased in intrahepatic cholangiocarcinoma (iCCA), a cancer with rising incidence. Restoring miR-885-5p levels may inhibit iCCA progression and offer a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Intrahepatic cholangiocarcinoma (iCCA) incidence is rising globally, yet its molecular drivers are unclear.
- MicroRNAs are increasingly recognized for their roles in cancer progression, including iCCA.
Purpose of the Study:
- To investigate the role of miR-885-5p in the molecular pathogenesis of iCCA.
- To identify potential therapeutic targets for iCCA based on microRNA regulation.
Main Methods:
- Quantitative analysis of miR-885-5p expression in iCCA tissues.
- In vitro and in vivo experiments using lentiviral vectors to manipulate miR-885-5p levels.
- Mechanistic studies to identify direct and indirect targets of miR-885-5p.
Main Results:
- miR-885-5p was significantly downregulated in iCCA tissues, correlating with poor survival outcomes.
- Modulating miR-885-5p levels affected iCCA cell proliferation and metastasis.
- miR-885-5p directly targets GALNT3 and indirectly downregulates IGF2BP1, inhibiting iCCA growth and metastasis.
- miR-885-5p suppresses iCCA metastasis via the PI3K/AKT/MMPs pathway by targeting GALNT3.
Conclusions:
- miR-885-5p acts as a tumor suppressor in iCCA by regulating GALNT3 and IGF2BP1.
- miR-885-5p is a potential therapeutic target for intrahepatic cholangiocarcinoma treatment.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025